Patient Preferences for Attributes of Biologic Treatments in Moderate to Severe Asthma: A Discrete Choice Experiment Study von Yang, Min, Chao, Jingdong, Fillbrunn, Mirko, Mallya, Usha G, Wang, Min-Jung, Franke, Leigh, Cohn, Lauren, Kamat , Siddhesh

Volltext

EE407 Treatment Patterns and Healthcare Resource Utilization in Ruxolitinib-Treated Patients with Myelofibrosis with and without Anemia: A Real-World Analysis von Liu, T, Fillbrunn, M, Chen, J, Sajeev, G, Zhang, S, Signorovitch, J

Volltext

104P Matching-adjusted indirect comparison for treatment of NTRK fusion cancer with larotrectinib versus entrectinib von Garcia-Foncillas, J., Bokemeyer, C., Italiano, A., Keating, K., Paracha, N., Fellous, M., Marian, M., Fillbrunn, M., Gao, W., Ayyagari, R., Lassen, U.N.

Volltext

P.68 Validation of a composite prognostic score for time to loss of ambulation in Duchenne muscular dystrophy von McDonald, C., Gordish-Dressman, H., Signorovitch, J., Sajeev, G., Fillbrunn, M., Frean, M., Ward, S., Goemans, N., Vandenborne, K., Mercuri, E., Muntoni, F.

Volltext

P.202A composite prognostic score for time to loss of walking ability in Duchenne muscular dystrophy (DMD) von Goemans, N., Signorovitch, J., Sajeev, G., Fillbrunn, M., Wong, H., Ward, S., McDonald, C., Mercuri, E.

Volltext

PRO126 A COMPOSITE PROGNOSTIC SCORE FOR TIME TO LOSS OF WALKING ABILITY IN DUCHENNE MUSCULAR DYSTROPHY (DMD) von Goemans, N., Signorovitch, J., Sajeev, G., Fillbrunn, M., Wong, H., Ward, S.J., McDonald, C., Mercuri, E.

Volltext

DMD/BMD – OUTCOME MEASURES: EP.123 Functional trajectories of upper limb and pulmonary function before and after loss of ambulation in Duchenne muscular dystrophy von Goemans, N., Signorovitch, J., McDonald, C., Mercuri, E., Niks, E., Wong, B., Sajeev, G., Fillbrunn, M., Yim, E., Dieye, I., Ward, S.

Volltext

DMD/BMD – OUTCOME MEASURES von Goemans, N., Signorovitch, J., McDonald, C., Mercuri, E., Niks, E., Wong, B., Sajeev, G., Fillbrunn, M., Yim, E., Dieye, I., Ward, S.

Volltext

P.126 Genotype-unmatched controls are feasible for drug development in Duchenne muscular dystrophy (DMD) von Muntoni, F., Signorovitch, J., Frean, M., Fillbrunn, M., Sajeev, G., Ward, S., McDonald, C., Goemans, N., Niks, E., Wong, B., Servais, L., Straub, V., de Groot, I., Chesshyre, M., Tian, C., Manzur, A., Mercuri, E., Aartsma-Rus, A., Groups, Study

Volltext

DMD & BMD – CLINICAL: P.55 Prognostic factors for loss of ability to rise from supine in Duchenne muscular dystrophy (DMD) von Goemans, N., McDonald, C., Signorovitch, J., Sajeev, G., Fillbrunn, M., Wong, H., Mercuri, E., Vandenborne, K., Muntoni, F., Ward, S., ImagingDMD study, The, iMDEX, cTAP

Volltext

DMD & BMD – CLINICAL von Goemans, N., McDonald, C., Signorovitch, J., Sajeev, G., Fillbrunn, M., Wong, H., Mercuri, E., Vandenborne, K., Muntoni, F., Ward, S., ImagingDMD study, The, iMDEX, cTAP

Volltext

Benefits of autoantibody enrichment in early RA: analysis of efficacy outcomes in four pooled abatacept trials von Michaud, K, Conaghan, P, Park, SH, Lozenski, K, Fillbrunn, M, Khaychuk, V, Swallow, E, Vaile, J, Lane, H, Nguyen, H, Pope, J

Volltext bestellen

Functional trajectories before and after loss of ambulation in Duchenne muscular dystrophy and implications for clinical trials von McDonald, Craig M, Signorovitch, James, Mercuri, Eugenio, Niks, Erik H, Wong, Brenda, Fillbrunn, Mirko, Sajeev, Gautam, Yim, Erica, Dieye, Ibrahima, Miller, Debra, Ward, Susan J, Goemans, Nathalie

Volltext

Functional trajectories before and after loss of ambulation in Duchenne muscular dystrophy and implications for clinical trials von McDonald, Craig M, Signorovitch, James, Mercuri, Eugenio, Niks, Erik H, Wong, Brenda, Fillbrunn, Mirko, Sajeev, Gautam, Yim, Erica, Dieye, Ibrahima, Miller, Debra, Ward, Susan J, Goemans, Nathalie

Volltext

Diversity-Driven Widening of Hierarchical Agglomerative Clustering von Fillbrunn, Alexander, Berthold, Michael R.

Volltext